Ravinder S. Singha, the Managing Director of Firmlink Pharma, discusses the unique business model they offer to their clients, their key success factors in entering new and sometimes challenging markets, as well as his views on the potential seen in many of the dynamic pharma markets around the world. He also shares his vision for the company’s continued success in the coming years.
As an introduction for our readers, how would you define the business model of Firmlink Pharma?
"The number one motivator [for setting up Firmlink Pharma's regulatory hub in the Philippines] was that the Philippines scores high on evolved regulatory practices and registration process transparency."
